
TSE:BNS
This summary was created by AI, based on 30 opinions in the last 12 months.
The Bank of Nova Scotia (BNS) has elicited mixed reviews from experts. Some highlight its strong positioning for future growth due to investments in GenAI and a favorable regulatory environment that allows for increased lending capacity. However, others express concerns about BNS's performance relative to its Canadian peers, noting it as the weakest among them despite a decent dividend yield of around 4.5% and recent strategic moves to invest in the U.S. market through KEY. While some analysts see potential for long-term gains, particularly with the new CEO at the helm, others urge caution citing stagnant loan growth and rising provisions for credit losses (PCLs). The overall sentiment reflects a blend of optimism for its turnaround and skepticism about its ability to catch up to its competitors amidst ongoing economic challenges.
The caller asked him to compare investing in ScotiaBank with investing in large cap American banks. In his 40 years in this business, most US banks have been bankrupt at least once, whereas the Canadian banks have not. The difference is the stronger regulatory system up here. He does own Morgan Stanley, which is a large US bank. ScotiaBank has been weak this year because of a few acquisitions and because of exposure in South America. There are fears that this might not do as well as expected. He is continuing to buy the stock but thinks it might be a few more quarters before people feel comfortable investing in South America. Events in Venezuela, for example, are causing disruptions in nearby countries, if only from the flow of emigrants.
It has had a tougher go as of late. They are the most internationally exposed bank. They have theoretically greater risk, but they have been through multiple cycles like this and have been fine. It lacks the momentum he wants. He wants the share price to stabilize. They have been cutting costs and reconciling businesses and the fruits of this will come in the near future. We need to see them beat once or twice.
Stock is down 8% YTD. Maybe they overpaid in recent purchases--we'll see in a few years if it paid off. More pressure comes from the NAFTA talks, since BNS has operations in Mexico. There's also weakness in emerging markets, and BNS has more exposure there than the other big banks. However, their last quarter--core earnings and domestic retail was fine, with international retail better than expected. This will go from the worst to the best perfomer in this space. (4.5% dividend, Analysts' price target: $85.46)
Footprint across Mexico and Latin America. 14% ROE and grows earnings 7% a year. Dividend grower, too. They have excess capital and have closed five purchases in the past year including a Chilean one. 7% earnings growth which the dividends leads towards double-digit returns. It will continue to outperform the TSX. (4.5% dividend, Analysts' price target: $85.46)
This is down year to date and has lagged the group. This was the only one of the large Canadian banks that missed estimates last quarter. The bank did some big acquisitions and offered equity at the $76 level (close to the current price of $75.12) to fund acquisitions. She thinks the price is attractive--the bank is well managed, they’ve put money into the wealth management area, which she expects to be a long-term growth area. She owns some ScotiaBank. It has not been a core holding but she is buying now, viewing the current price as an entry point. Yield 4.5%.
He would not buy this because the stock has done incredibly well. A slowdown in housing in Canada will affect all the banks. There is not much negative to say about ScotiaBank. They have investments in emerging markets, especially Latin America, which could cause them a bit of pain, but this would create opportunities for investors rather than taking down the bank. Scotia has a strong retail presence in Canada. It will ride up and down a bit with the economy and currency. He sees this company as a well-balanced operation. He just wants a better entry point.
Clients are paying him to think outside of what is obvious. This one has not participated in the same way as the others in this rally. This is the most global Canadian bank. He likes it from a valuation perspective. It underperformed because of emerging markets. In the past we saw this one go from the worst performing Canadian bank to the best performing one in a year and we see the same thing playing out here. (Analysts’ target: $86.43).
Exposed to Latin America which is sensitive to commodities. Trading at a lower book multiple than its peers and have strengthened its franchise here and abroad. Balance sheet is healthy. They've invested a lot into IT. It's not too late to buy Canadian banks, and still a good time given likely dividend increases and the fact that they are off their all-time highs. (4% dividend, $86.43 analysts' price target)
Worst performer of all the banks for the year. They made two big acquisitions in the wealth management. He thinks it is a screaming buy here. You can’t be too pessimistic on the Canadian Economy. (Analysts’ price target is $86.46)